1. Home
  2. USPH vs RAPP Comparison

USPH vs RAPP Comparison

Compare USPH & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Physical Therapy Inc.

USPH

U.S. Physical Therapy Inc.

N/A

Current Price

$77.62

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

RAPP

Rapport Therapeutics Inc.

N/A

Current Price

$28.95

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
USPH
RAPP
Founded
1990
2022
Country
United States
United States
Employees
5500
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
USPH
RAPP
Price
$77.62
$28.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$105.60
$48.50
AVG Volume (30 Days)
185.8K
313.3K
Earning Date
01-01-0001
06-22-2026
Dividend Yield
2.30%
N/A
EPS Growth
N/A
24.34
EPS
1.42
N/A
Revenue
$780,990,000.00
N/A
Revenue This Year
$9.44
N/A
Revenue Next Year
$6.43
N/A
P/E Ratio
$56.23
N/A
Revenue Growth
16.33
N/A
52 Week Low
$62.77
$7.73
52 Week High
$93.50
$42.27

Technical Indicators

Market Signals
Indicator
USPH
RAPP
Relative Strength Index (RSI) 33.74 49.34
Support Level $77.28 $25.40
Resistance Level $83.08 $29.84
Average True Range (ATR) 3.20 2.01
MACD -0.58 -0.01
Stochastic Oscillator 34.40 46.56

Price Performance

Historical Comparison
USPH
RAPP

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: